Intestinal Obstruction: Clinical Trials

16 trials for Intestinal Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 16 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 16
Phase 13Completed 3
Phase 31Completed 1

Follow Intestinal Obstruction: new trials by email Literature Review of Intestinal Obstruction trials Research Report on Intestinal Obstruction

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Follow-up and Steroid Treatment Results in Intussusception
Methylprednisolone - Intussusception
Phase 1 / Phase 2CompletedBaskent University922019-12-242025-02-05
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
LB1148, Placebo - Ileus, Post-Operative Adhesions
Phase 2CompletedPalisade Bio1122019-10-012024-06-21
Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus
LB1148, Placebo - Ileus
Phase 2CompletedNewsoara Biopharma Co., Ltd.1312019-07-092021-09-27
Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention
Methylnaltrexone, Placebo - Postoperative Ileus
Phase 2CompletedOhio State University822019-02-212021-10-27
The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection
Foeniculum Vulgare Seed Ironing - Colorectal Surgery, Foeniculum
Phase 2CompletedWest China Hospital3002018-10-202019-09-17
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer
Cediranib - Bowel Obstruction, Ovarian Cancer
Phase 2CompletedProf Gordon Jayson302018-05-142026-06-15
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
Lanreotide Autogel - Intestinal Obstruction
Phase 2CompletedIpsen522014-11-192019-04-16
The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section
Gum chewing - Paralytic Ileus
Phase 2 / Phase 3CompletedChiang Mai University1002010-05-012011-06-28
Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
Eluxadoline, Placebo - Irritable Bowel Syndrome
Phase 2CompletedFuriex Pharmaceuticals, Inc8072010-04-282019-10-22
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Ipamorelin, placebo - Ileus
Phase 2CompletedHelsinn Therapeutics (U.S.), Inc1172008-04-012017-04-14
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial
Phase 2CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.1462007-10-012019-03-19
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Octreotide LAR, Octreotide (Immediate release), methylprednisolone - Peritoneal Neoplasms, Intestinal Obstruction
Phase 2CompletedNovartis Pharmaceuticals642005-09-012011-09-23
Movicol in Childhood Constipation (ProMotion Study)
Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol), Lactulose - Feces, Impacted
Phase 2CompletedNorgine602000-10-012007-01-04
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
bowel obstruction management, quality-of-life assessment - Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction
Phase 1 / Phase 2CompletedNorthwestern University2000-01-012012-06-06
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
bowel obstruction management, quality-of-life assessment - Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction
Phase 1 / Phase 2CompletedNorthwestern University2000-01-012012-06-06
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
octreotide acetate - Colorectal Cancer, Constipation, Impaction, and Bowel Obstruction
Phase 2CompletedNorthwestern University1999-10-012012-06-06

Narrower conditions

Ileus (6)  ·  Colonic Neoplasms (3)  ·  Colorectal Neoplasms (3)  ·  Constipation (3)  ·  Gastrointestinal Stromal Tumors (3)  ·  Stomach Neoplasms (3)  ·  Bile Duct Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Rectal Neoplasms (2)  ·  Abdominal Abscess (1)  ·  Bacterial Infections (1)  ·  Carcinoma (1)  ·  Carcinoma, Ovarian Epithelial (1)

Broader conditions

Digestive System Diseases (15)  ·  Gastrointestinal Diseases (15)  ·  Intestinal Diseases (15)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Digestive System Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Colonic Diseases (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Neoplasms (3)

Interventions

Methylprednisolone (2)  ·  Octreotide (2)  ·  Chewing Gum (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Doripenem (1)  ·  Exercise (1)  ·  Lactulose (1)  ·  Steroids (1)  ·  cediranib (1)  ·  eluxadoline (1)  ·  ipamorelin (1)  ·  methylnaltrexone (1)

Sponsors

Northwestern University (3)  ·  Baskent University (1)  ·  Chiang Mai University (1)  ·  Furiex Pharmaceuticals, Inc (1)  ·  Helsinn Therapeutics (U.S.), Inc (1)  ·  Ipsen (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Newsoara Biopharma Co., Ltd. (1)  ·  Norgine (1)  ·  Novartis Pharmaceuticals (1)  ·  Ohio State University (1)  ·  Palisade Bio (1)  ·  Prof Gordon Jayson (1)  ·  West China Hospital (1)

Countries

United States (7)  ·  China (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  France (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Top investigators

Willis G. Parsons, MD, PC (2)  ·  Andrew Clamp (1)  ·  David CA Candy, MD (1)  ·  J. Cameron Muir, MD (1)  ·  Kittipat Charoenkwan, MD (1)  ·  Mitch Jones, MD (1)  ·  Suzan Allen (1)  ·  Ziqiang Wang, MD (1)

Results publications

PMID 15351109, PMID 16819379, PMID 16850151, PMID 19610681, PMID 20334152, PMID 23583433, PMID 24813429, PMID 25331030, PMID 25819420, PMID 26867333, PMID 28167156, PMID 29067571, PMID 29621360, PMID 34798295, PMID 34844770, PMID 39914152

NIH funding

2016 (1)